SOUTH SAN FRANCISCO, California and VANCOUVER, Canada, May 11, 2023 /PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that the...
News Ticker
- [ June 4, 2023 ] Vial to Sponsor and Present at Clinical Trials at the Summit (CTS) 2023 in Park City, UT News
- [ June 4, 2023 ] Promising Data for Investigational Innovative Bispecific Ivonescimab Featured at ASCO 2023 News
- [ June 3, 2023 ] GRAIL Presents Real-World Experience With The Galleri® Multi-Cancer Early Detection Test At 2023 ASCO Annual Meeting News
- [ June 3, 2023 ] New PATHFINDER Study Analysis Demonstrates Efficient Diagnostic Resolution Following Multi-Cancer Early Detection Testing News
- [ June 3, 2023 ] ASCO: Gilead, Arcus inject a bit more hope into TIGIT tale with reduced risk of lung cancer progression News
Copyright © 2023 Biotech Networks, LLC
